Corbus Pharmaceuticals Stock (NASDAQ: CRBP) stock price, news, charts, stock research, profile.
You can purchase shares of Corbus Pharmaceuticals (NASDAQ:CRBP) through any online brokerage.
Other companies in Corbus Pharmaceuticals’s space includes: Macrogenics (NASDAQ:MGNX), Molecular Partners (NASDAQ:MOLN), Zura Bio (NASDAQ:ZURA), Galectin Therapeutics (NASDAQ:GALT) and Inozyme Pharma (NASDAQ:INZY).
Corbus Pharmaceuticals has a consensus price target of $65.86.
The stock price for Corbus Pharmaceuticals (NASDAQ: CRBP) is $16.51 last updated November 21, 2024 at 11:08 AM EST.
There are no upcoming dividends for Corbus Pharmaceuticals.
Corbus Pharmaceuticals’s Q3 earnings are confirmed for Thursday, November 7, 2024.
There is no upcoming split for Corbus Pharmaceuticals.
Corbus Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.